Andrew Cheng, President and CEO at Akero Therapeutics, Inc. (AKRO), sold 15,788 shares at $22.64 ($357K) on 2024-06-11, disclosed to the SEC on 2024-06-13.
Open-market sale of $357k AKRO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.64 | 7,894 | $179K | 50.0% |
| 2 | $22.64 | 7,894 | $179K | 50.0% |
| Total | $22.64 avg | 15,788 | $357K | 100% |
| Filing → |
| AKRO | SELL | 2025-08-13 | $2.9M | — | Filing → |
| AKRO | SELL | 2025-07-11 | $3.1M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $726K | — | Filing → |